Dual antiplatelet therapy in coronary artery disease: A case-based approach

被引：2

作者：

Raymond, Chad ^{[2
]}

Menon, Venu ^{[1
]}

机构：

[1] Cleveland Clin, Coronary Care Unit, Cardiovasc Inst, Cleveland, OH 44195 USA

[2] Cleveland Clin, Inst Internal Med, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2009年 / 76卷 / 11期

关键词：

SIROLIMUS-ELUTING STENTS; MYOCARDIAL-INFARCTION; CLOPIDOGREL; ASPIRIN; PRASUGREL; INTERVENTION; TICLOPIDINE; THROMBOSIS; METAANALYSIS; AGGREGATION;

D O I：

10.3949/ccjm.76a.09045

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Current guidelines support dual antiplatelet therapy with aspirin and clopidogrel (Plavix) in a number of clinical scenarios, ie, in ST-segment-elevation myocardial infarction (MI), non-ST-elevation MI, and percutaneous coronary intervention. The guidelines are based on strong evidence from several large randomized clinical trials over the last 10 years. The authors present several cases to show how to put this evidence into day-to-day clinical practice.

引用

页码：663 / 670

页数：8

共 50 条

[1] Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease
Valgimigli, Marco
Bueno, Hector
Byrne, Robert A.
Collet, Jean-Philippe
Costa, Francesco
Jeppsson, Anders
Juni, Peter
Kastrati, Adnan
Kolh, Philippe
Mauri, Laura
Montalescot, Gilles
Neumann, Franz-Josef
Petricevic, Mate
Roffi, Marco
Steg, Philippe Gabriel
Windecker, Stephan
Luis Zamorano, Jose
Berenguer Jofresa, Alberto
Biscevic, Adela
Calabro, Paolo
Constantinides, Savvas
Damrina, Elena
Diakite, Moustapha
Dzudovic, Boris
Garcia Ruiz, Victoria
Keituqwa Yanez, Ivan
Lacalzada-Almeida, Juan
Leite, Luis
Maskon, Oteh
Myat, Lin Lin
Ricottini, Elisabetta
Saporito, Francesco
Wong, Peter Sze Chai
Yamaji, Kyohei
Zeitouni, Michel
[J]. EUROPEAN HEART JOURNAL, 2018, 39 (03) : E1 - E33
[2] Dual Antiplatelet Therapy for Coronary Artery Disease
Lee, Cheol Whan
[J]. CIRCULATION JOURNAL, 2015, 79 (02) : 255 - 262
[3] Dual Antiplatelet Therapy in Coronary Artery Disease
Sharma, Raghav
Kumar, Prathap
Prashanth, S. P.
Belagali, Yogesh
[J]. CARDIOLOGY AND THERAPY, 2020, 9 (02) : 349 - 361
[4] Optimal duration of dual antiplatelet therapy for coronary artery disease
Kikkert, W. J.
Damman, P.
[J]. NETHERLANDS HEART JOURNAL, 2018, 26 (06) : 321 - 333
[5] Optimal duration of dual antiplatelet therapy for coronary artery disease
W. J. Kikkert
P. Damman
[J]. Netherlands Heart Journal, 2018, 26 : 321 - 333
[6] Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients
Mackman, Nigel
Spronk, Henri M. H.
Stouffer, George A.
ten Cate, Hugo
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (04) : 726 - 732
[7] Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article
Alex D. Moseley
Fareed M. Collado
Annabelle Santos Volgman
Gary L. Schaer
R. Jeffrey Snell
[J]. Current Atherosclerosis Reports, 2016, 18
[8] Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article
Moseley, Alex D.
Collado, Fareed M.
Volgman, Annabelle Santos
Schaer, Gary L.
Snell, R. Jeffrey
[J]. CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (07)
[9] Focused Update on Duration of Dual Antiplatelet Therapy for Patients With Coronary Artery Disease
Mauri, Laura
Smith, Sidney C., Jr.
[J]. JAMA CARDIOLOGY, 2016, 1 (06) : 733 - 734
[10] Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
Tung, Ying-Chang
See, Lai-Chu
Chang, Shu-Hao
Liu, Jia-Rou
Kuo, Chi-Tai
Chang, Chi-Jen
[J]. SCIENTIFIC REPORTS, 2020, 10 (01)

← 1 2 3 4 5 →